Traditional Chinese Medicine Flavonoid Extract Shows Promise for Stroke Recovery Through Enhanced Angiogenesis
核心洞察
A novel Pickering emulsion (搜索) delivery system for total flavonoids from Dracocephalum moldavica L. (搜索) (TFDM (搜索)) demonstrated 163.55% improved bioavailability compared to conventional oral administration in stroke treatment studies.
TFDM (搜索) treatment significantly reduced cerebral infarct volume and improved neurological function scores in rat models of cerebral ischemia-reperfusion injury (搜索), with effects becoming statistically significant by day 7 post-treatment.
The therapeutic mechanism involves upregulation of angiogenesis-related proteins VEGF (搜索), VEGFR2 (搜索), and CD34 (搜索) in ischemic brain regions, promoting blood vessel formation and improving tissue perfusion in stroke-affected areas.
A breakthrough study has demonstrated that total flavonoids extracted from Dracocephalum moldavica L. (TFDM (搜索)), delivered through an innovative Pickering emulsion (搜索) system, significantly improves stroke recovery by promoting angiogenesis and enhancing drug bioavailability. The research, conducted by investigators at Baotou Medical College (搜索), represents a novel approach to addressing the limited therapeutic options available for ischemic stroke (搜索) treatment.
Enhanced Extraction and Delivery System
The research team developed an optimized ultrasonic extraction protocol that achieved 65% extraction efficiency for TFDM (搜索) under specific conditions: 62°C temperature, 65% ethanol volume percentage, 40:1 solvent-to-material ratio, and 2.5-hour extraction time. This represents a significant improvement over traditional water-based extraction methods commonly used for this medicinal herb.
To address the inherent instability and poor bioavailability of flavonoids, researchers encapsulated TFDM (搜索) in a novel Pickering emulsion (搜索) using sodium starch octenyl succinate (SSOS), chitosan (CS), and tannic acid (TA). The resulting formulation achieved 87.2% encapsulation efficiency and demonstrated superior pharmacokinetic properties.
Significant Bioavailability Improvement
Pharmacokinetic studies in rats revealed that the TFDM (搜索)-Pickering emulsion (搜索) formulation achieved a relative bioavailability of 163.55% compared to conventional aqueous TFDM administration. The enhanced formulation showed a maximum plasma concentration (Cmax) of 28.98 μg/mL versus 19.64 μg/mL for the standard preparation, with both formulations reaching peak concentrations at 120 minutes post-administration.
Therapeutic Efficacy in Stroke Models
Using a middle cerebral artery occlusion (MCAO) reperfusion model in Sprague-Dawley rats, researchers evaluated TFDM (搜索)'s therapeutic potential across multiple timepoints. Animals receiving 50 mg/kg TFDM showed significant improvements in neurological function and reduced brain tissue damage.
Temporal analysis revealed that cerebral infarct volume in TFDM (搜索)-treated rats was significantly lower than control groups on days 7 and 14 post-treatment (p < 0.01). Similarly, modified Neurological Severity Score (mNSS) assessments showed progressive improvement, with statistically significant differences emerging by day 7.
Angiogenesis Mechanism Elucidated
The study provided comprehensive evidence for TFDM (搜索)'s mechanism of action through enhanced angiogenesis. Immunohistochemical analysis revealed significantly elevated expression of key angiogenic factors in the ischemic penumbra of TFDM-treated animals.
VEGF (搜索)-positive cell counts peaked on day 7 post-treatment in the TFDM (搜索) group, showing significantly higher levels than control animals (p < 0.01). VEGFR2 (搜索) expression was significantly increased on days 3 and 7, while CD34 (搜索)-positive cells peaked on day 3 before gradually declining, consistent with the temporal pattern of post-stroke tissue repair.
Western blot analysis confirmed these findings, with VEGF (搜索) protein expression significantly elevated on days 3 and 7 in TFDM (搜索)-treated animals compared to controls (p < 0.05). VEGFR2 (搜索) protein levels showed similar patterns, while CD34 (搜索) expression peaked on day 3 post-treatment.
Improved Cerebral Perfusion and Microvascular Formation
FITC-dextran perfusion studies demonstrated enhanced blood flow in the ischemic penumbra of TFDM (搜索)-treated animals. Laser confocal microscopy revealed significantly improved cerebral microvascular perfusion on days 7 and 14 compared to control groups.
Detailed microvascular analysis showed that TFDM (搜索) treatment promoted the formation of smaller diameter blood vessels, with 71.6% and 63.5% of vessels measuring less than 4 μm in diameter on days 3 and 7, respectively, compared to control animals (p < 0.01). This pattern suggests active neovascularization in response to treatment.
Neuroprotective Effects
Nissl staining revealed that TFDM (搜索) treatment significantly reduced neuronal damage in the ischemic penumbra. While control animals showed disordered cell arrangement, swollen cell bodies, and reduced Nissl body numbers, TFDM-treated animals exhibited less severe cellular disorganization and better preservation of neuronal structure.
Clinical Translation Potential
The study's findings suggest that TFDM (搜索) delivered via Pickering emulsion (搜索) represents a promising therapeutic strategy for stroke treatment. The combination of traditional Chinese medicine with modern drug delivery technology addresses key limitations of conventional flavonoid therapies, including poor stability and low bioavailability.
The research demonstrates that TFDM (搜索)'s therapeutic effects likely involve dual mechanisms: activation of the VEGF (搜索)/tyrosine protein kinase SRC signaling pathway to promote angiogenesis, and activation of the PI3K/AKT (搜索) signaling pathway to prevent cell apoptosis. These pathways are crucial for vascular formation and neuroprotection in stroke recovery.
Future Implications
This research provides a foundation for developing novel stroke therapies that combine traditional medicinal knowledge with advanced pharmaceutical technologies. The Pickering emulsion (搜索) delivery system could potentially be applied to other bioactive compounds with similar stability and bioavailability challenges.
The study's comprehensive approach, examining multiple timepoints and employing various analytical techniques, provides robust evidence for TFDM (搜索)'s therapeutic potential. However, translation to clinical applications will require additional studies to establish optimal dosing regimens and safety profiles in human populations.
